Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-01-16
DOI
10.1111/apt.17386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P383 Ustekinumab as an opportunity for refractory Ulcerative Colitis patients
- (2022) M Iborra et al. Journal of Crohns & Colitis
- A146 THE EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN PATIENTS WITH ULCERATIVE COLITIS
- (2022) L Albino et al. Journal of the Canadian Association of Gastroenterology
- Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
- (2022) Maria T Abreu et al. Journal of Crohns & Colitis
- Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
- (2022) Joel Thunberg et al. United European Gastroenterology Journal
- Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
- (2022) Cristina Rubín de Célix et al. Journal of Clinical Medicine
- Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial
- (2021) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
- (2021) Carlos Taxonera et al. INFLAMMATORY BOWEL DISEASES
- Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
- (2021) Rahul S. Dalal et al. Clinical Gastroenterology and Hepatology
- Sa555 COLECTOMY-FREE DRUG SURVIVAL OF USTEKINUMAB IN ULCERATIVE COLITIS: A REAL-WORLD, MULTICENTER COHORT STUDY IN THE UNITED STATES
- (2021) Rahul S. Dalal et al. GASTROENTEROLOGY
- Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis
- (2021) Rahul S Dalal et al. INFLAMMATORY BOWEL DISEASES
- Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
- (2021) Mathurin Fumery et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- One-year effectiveness and safety of ustekinumab in Ulcerative Colitis: a multicenter real-world study from Italy
- (2021) Michele Francesco Chiappetta et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
- (2020) Aurélien Amiot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis
- (2020) Katherine Li et al. GASTROENTEROLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
- (2019) Thomas Ochsenkühn et al. United European Gastroenterology Journal
- Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
- (2018) Stefan Schreiber et al. JOURNAL OF GASTROENTEROLOGY
- Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis
- (2017) Carlos Taxonera et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
- (2016) Carlos Taxonera et al. DIGESTIVE DISEASES AND SCIENCES
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
- (2012) Christina Ha et al. Clinical Gastroenterology and Hepatology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started